Analytical Support of Classical Anticonvulsant Drug Monitoring beyond Immunoassay: Application of Chromatographic Methods

Advances in Chromatographic Techniques for Therapeutic Drug Monitoring

Volumn , Issue , 2009, Pages 85-101

  Juenke, JoEtta ^a   McMillin, Gwendolyn A ^b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052541279     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420067590-11     Document Type: Chapter

References (63)

1. Martin AJP, Synge RLM. 1941. A new form of chromatography employing two liquid phases: I. A theory of chromatography. II. Applications to the micro determination of the higher monoamino acids in proteins. Biochem J, 35: 1358-1368.
2. Ettre LS. 1993. Nomenclature for chromatography: IUPAC recommendations 1993. Pure Appl Chem, 65: 819-872.
3. James AT, Martin AJP. 1952. Separation and identification of methyl esters of saturated and unsaturated fatty acids from n-pentanoic to n-octadecanoic acids. Analyst, 77: 915-920.
4. Dorsey JG. 2000. Liquid chromatography: introduction. In Meyers, RA (ed), Encyclopedia of Analytical Chemistry. Chichester, UK: John Wiley & Sons, 1123-1133.
5. Johannessen SI, Battino D, Berry DJ, Bialer M, et al. 2003. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25: 347-363.
6. Baselt R. 2004. Phenytoin. Disposition of Toxic Drugs and Chemicals in Man, 7th edition. Foster City, CA: Biomedical Publications, 901-903.
7. Baselt R. 2004. Fosphenytoin. Disposition of Toxic Drugs and Chemicals in Man, 7th edition. Foster City, CA: Biomedical Publications, 493.
8. Datta P, Dasgupta A. 1998. Cross-reactivity of fosphenytoin in four phenytoin immunoassays. Clin Chem, 44: 696-697.
9. Kugler AR, Annesley TM, Nordblom GD, Koup JR, Olson SC. 1998. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays. Clin Chem 44(7): 1474-1480.
10. Roberts WL, De BK, Coleman JP, Annesley TM. 1999. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin. Clin Chem 45: 829-837.
11. Dasgupta A, Handy BC, Datta P. 2000. Mathematical model to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase. Am J Clin Pathol 113: 87-92.
12. Annesley TM, Kurzyniec S, Nordblom GD, Buchanan N, et al. 2001. Glucuronidation of prodrug reactive site: isolation and characterization of oxymethylglucuronide metabolite of fosphenytoin. Clin Chem 46: 910-918.
13. McDonald DM, Kabra PM. 1980. Renal disease may increase apparent phenytoin in serum as measured by enzyme-multiplied immunoassay. Clin Chem 26: 361-362.
14. Rainey PM, Rogers KE, Roberts WL. 1996. Metabolite and matrix interference in phenytoin immunoassays. Clin Chem 42: 1645-1653.
15. Reeves SE, Hanyok JJ, Amon SA, Godley PJ. 1985. Discrepancy in serum phenytoin concentrations determined by two immunoassay methods in uremic patients. Am J Hosp Pharm 42(2): 359-361.
16. Roberts WL, Annesley TM, De BK, Moulton L, et al. 2001. Performance characteristics of four free phenytoin immunoassays. Ther Drug Monit 23: 148-154.
17. Sirgo MA, Green PJ, Rocci ML Jr, Vlasses PH. 1984. Interpretation of serum phenytoin concentrations in uremia is assay-dependent. Neurology 34: 1250-1251.
18. Tutor-Crespo MJ, Hermida J, Tutor JC. 2007. Phenytoin immunoassay measurements in serum samples from patients with renal insufficiency: comparison with high-performance liquid chromatography. J Clin Lab Anal 21: 119-123.
19. Ritz DP. 1975. Single extraction GLC analysis of six commonly prescribed antiepileptic drugs. Clin Toxicol 8: 311-324.
20. Abraham CV, Joslin HD. 1976. Simultaneous gas chromatographic analysis for the four commonly used antiepileptic drugs in serum. J Chromatogr 128: 281-287.
21. Chang T, Glazko AJ. 1970. Quantitative assay of 5, 5-diphenylhydantoin (Dilantin) and 5-(phydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography. J Lab Clin Med 75: 145-155.
22. Kupferberg HJ. 1970. Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography. Clin Chim Acta 29: 282-288.
23. Nelson MH, Birnbaum AK, Nyhus PJ, Remmel RP. 1998. A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies. J Pharm Biomed Anal 17: 1311-1323.
24. Vandemark FL, Adams RF. 1976. Ultramicro gas-chromatographic analysis for anticonvulsants, with use of a nitrogen-selective detector. Clin Chem 22: 1062-1065.
25. Patil KM, Bodhankar, SL. 2005. Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal 39: 181-186.
26. Ramachandran S, Underhill S, Jones SR. 1994. Measurement of lamotrigine under conditions measuring phenobarbitone, phenytoin, and carbamazepine using reversed-phase high-performance liquid chromatography at dual wavelengths. Ther Drug Monit 16: 75-82.
27. Romanyshyn LA, Wichmann JK, Kucharczyk N, Shumaker RC et al. 1994. Simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high performance liquid chromatography. Ther Drug Monit 16: 90-99.
28. Subramanian M, Birnbaum AK, Remmel RP. 2008. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther Drug Monit 30: 347-356.
29. Parant F, Moulsma M, Gagnieu MC, Lardet, G. 2005. Hydroxyzine and metabolites as a source of interference in carbamazepine particle enhanced turbidimetric immunoassays (PENTINA). Ther Drug Monit 27: 457-462.
30. Contin M, Riva R, Albani F, Perucca E, Baruzzi, A. 1985. Determination of total and free plasma carbamazepine concentrations by enzyme multiplied immunoassay: interference with the 10, 11-epoxide metabolite. Ther Drug Monit 7: 46-50.
31. Hermida J, Tutor JC. 2003. How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine 10, 11-epoxide in serum samples? Ther Drug Monit 25: 384-388.
32. Kumps A, Mardens Y. 1986. Cross-reactivity assessment of oxcarbazepine and its metabolites in the EMIT assay of carbamazepine plasma levels. Ther Drug Monit 8: 95-97.
33. Parant F, Bossu H, Gagnieu MC, Lardet G, Moulsma M. 2003. Cross-reactivity assessment of carbamazepine-10, 11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000. Ther Drug Monit 25: 41-45.
34. Tutor-Crespo MJ, Hermida J, Tutor JC. 2008. Relative proportion of serum carbamazepine and its pharmacologically active 10, 11-epoxide derivative: effect of polytherapy and renal insufficiency. Ups J Med Sci 113: 171-180.
35. Millner SN, Taber CA. 1979. Rapid gas chromatographic determination of carbamazepine for routine therapeutic monitoring. J Chromatogr 163: 96-102.
36. Perchalski RJ, Wilder BJ. 1974. Rapid gas-liquid chromatographic determination of carbamazepine in plasma. Clin Chem 20: 492-493.
37. Schwertner HA, Hamilton HE, Wallace JE. 1978. Analysis for carbamazepine in serum by electron-capture gas chromatography. Clin Chem 24: 895-899.
38. Gerardin A, Abadie F, Laffont J. 1975. GLC determination of carbamazepine suitable for pharmacokinetic studies. J Pharm Sci 64: 1940-1942.
39. Lensmeyer GL. 1977. Isothermal gas chromatographic method for the rapid determination of carbamazepine (“tegretol”) as its TMS derivative. Clin Toxicol 11: 443-454.
40. Cocks DA, Dyer TF, Edgar K. 1981. Simple and rapid gas-liquid chromatographic method for estimating carbamazepine in serum. J Chromatogr 222: 496-500.
41. Hallbach J, Vogel H, Guder WG. 1997. Determination of lamotrigine, carbamazepine and carbamazepine epoxide in human serum by gas chromatography mass spectrometry. Eur J Clin Chem Clin Biochem 35: 755-759.
42. Babaei A, Eslamai MH. 2007. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. Int J Clin Pharmacol Ther 45: 121-125.
43. Bonato PS, Lanchote VL, deCarvalho D, Ache P. 1992. Measurement of carbamazepine and its main biotransformation products in plasma by HPLC. J Anal Toxicol 16: 88-92.
44. Elyas AA, Ratnaraj N, Goldberg VD, Lascelles PT. 1982. Routine monitoring of carbamazepine and carbamazepine-10, 11-epoxide in plasma by high-performance liquid chromatography using 10-methoxycarbamazepine as internal standard. J Chromatogr 231: 93-101.
45. Paxton JW. 1982. Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatography. Epilepsia 23: 185-189.
46. Tosoni S, Signorini C, Albertini A. 1983. Gas-chromatographic determination of valproic acid in serum without derivatization. Clin Chem 29: 990.
47. Wohler AS, Poklis A. 1997. A simple, rapid gas-liquid chromatographic procedure for the determination of valproic acid in serum. J Anal Toxicol 21: 306-309.
48. Yu HY, Shih MC. 1996. Determination of valproic acid in human plasma by capillary gas chromatography. Ther Drug Monit 18: 107-108.
49. Calendrillo BA, Reynoso G. 1980. A micromethod for the on-column methylation of valproic acid by gas-liquid chromatography. J Anal Toxicol 4: 272-274.
50. Morita Y, Ruo TI, Lee ML, Atkinson Jr AJ. 1981. On-column propylation method for measuring plasma valproate concentration by gas chromatography. Ther Drug Monit 3: 193-199.
51. Nishioka R, Kawai S, Toyoda S. 1983. New method for the gas chromatographic determination of valproic acid in serum. J Chromatogr 277: 356-360.
52. Darius J, Meyer FP. 1995. Sensitive capillary GC-MS method for the therapeutic drug monitoring of valproic acid and seven of it’s metabolites in human serum. J Chrom B 656: 343-353.
53. Braun SL, Tausch A, Vogt W, Jacob K, Knedel M. 1981. Evaluation of a new valproic acid enzyme immunoassay and comparison with a capillary gas-chromatographic method. Clin Chem 27: 169-172.
54. Leroux M, Budnik D, Hall K, Irvine-Meek J, et al. 1981. Comparison of gas-liquid chromatography and EMIT assay for serum valproic acid. Clin Biochem 14: 87-90.
55. Hara S, Kamura M, Inoue K, Kukuzawa M, et al. 1999. Determination of valproic acid in human serum by high performance liquid chromatography with fluorescence detection. Biol Pharm Bull 22: 975-977.
56. Zhong Y, Jiao Y, Yu Y. 2006. Simultaneous determination of mycophenolic acid and valproic acid based on derivatization by high performance liquid chromatography with fluorescence detection. Biomed Chromatogr 20: 319-326.
57. Kabra PM, McDonald DM, Marton LJ. 1978. A simultaneous high-performance liquid chromatographic analysis of the most common anticonvulsants and their metabolites in the serum. J Anal Toxicol 2: 127-133.
58. Queiroz ME, Silva SM, Carvalho D, Lancas FM. 2002. Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital and primidone in human plasma by SPME-GC-TSD. J Chromatogr Sci 40: 219-223.
59. Liu H, Delgado M, Forman LJ, Eggers CM, Montoy JL. 1999., Simultaneous determination of carbamazepine, phenytoin, phenobarbital, primidone and their principal metabolites by high-performance liquid chromatography with photodiode array detection. J Chromatogr 616: 105-115.
60. Wad N, Bourgeois B, Kramer G. 1999. Serum protein binding of desmethyl-methsuximide. Clin Neuropharmacol 22: 239-240.
61. Speed DJ, Dickinson SJ, Cairns ER, Kim, ND. 2000. Analysis of six anticonvulsant drugs using solid phase extraction, deuterated internal standard and gas chromatography-mass spectrometry. J Anal Toxicol 24: 685-690.
62. Ou CN, Rognerud, CL. 1984. Simultaneous measurement of ethosuximide, primidone, phenobarbital, phenytoin, carbamazepine and their bioactive metabolites by liquid chromatography. Clin Chem 30: 1667-1670.
63. Martar KM, Nicholls PJ, Tekle A, Bawazir SA, Al-Hassan, MI. 1999. Liquid chromatographic determination of six antiepileptic drugs and two metabolites in microsamples of human plasma. Ther Drug Monit 21: 559-566.